EGFR associated expression profiles vary with breast tumor subtype - Wikidata - awgldk - TriplyDB

EGFR associated expression profiles vary with breast tumor subtype

EGFR associated expression profiles vary with breast tumor subtype

http://www.wikidata.org/entity/Q33292502

about

Bayesian non-negative factor analysis for reconstructing transcription factor mediated regulatory networks DART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inference ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers Differential oestrogen receptor binding is associated with clinical outcome in breast cancer Quantification of HER family receptors in breast cancer FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer Wnt signaling in triple negative breast cancer is associated with metastasis Towards improved cancer diagnosis and prognosis using analysis of gene expression data and computer aided imaging.Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer.Estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2), and epidermal growth factor receptor expression and benefit from lapatinib in a randomized trial of paclitaxel with lapatinib or placebo as first-line treatme Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis.Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures.ERBB1 and ERBB2 have distinct functions in tumor cell invasion and intravasation.EGFR may couple moderate alcohol consumption to increased breast cancer risk.A fuzzy gene expression-based computational approach improves breast cancer prognostication Mask is required for the activity of the Hippo pathway effector Yki/YAP.Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2 Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts.Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression MEK inhibition potentiates the activity of Hsp90 inhibitor 17-AAG against pancreatic cancer cells.Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer.Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells.Molecular characterisation of cell line models for triple-negative breast cancers.Characteristics of triple-negative breast cancer MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells.Interactions with fibroblasts are distinct in Basal-like and luminal breast cancers.Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions.Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies.Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer.Compartmentalized Ras proteins transform NIH 3T3 cells with different efficiencies High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy Standard of care and promising new agents for triple negative metastatic breast cancer Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma.Can systems biology understand pathway activation? Gene expression signatures as surrogate markers for understanding the complexity of pathway activation.An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer.

P2860

Q21093269-9E8C7D2E-75E8-4C55-87E6-5245B3DC2C38 Q21284334-B795E63D-52A7-41F6-B1FC-1B26DA0DFC2F Q24303562-73960B1C-CD0F-477A-8BFE-167205ACA5D3 Q24595511-FE448B1D-EEA9-4647-99DE-D1B052EB008B Q27015506-23A83FFA-0964-41ED-8AE4-01E1565C3987 Q28077347-616EAA84-0B95-478D-8A46-CEF9249B45B5 Q29619481-08C2E20E-82D8-402B-8D19-43F11C999F59 Q30597238-3EE7B342-E71B-4340-B33C-A6AB059A1973 Q33459037-432F4899-A08F-41B3-A986-E4EA5E0E9DB8 Q33552870-85F4DA2C-50D0-4EFF-8ABB-04D67EBFE10A Q33561588-BC41A948-6787-4177-B599-2D94598C9B83 Q33562476-76B58249-CB7D-49A8-9F3F-6E80DA7E4E87 Q33618363-DCECC699-EECB-4316-81FF-FFB7676DBE51 Q33738285-F9D83C74-DBD5-4FEC-8E62-90BCDA98102E Q33788520-FC176C4B-8636-4FA9-A8DD-5CCBEBE14FCC Q33811642-C963D0C7-8D35-40A9-871F-5167D0F71FD4 Q33858538-C22487DD-20F5-4929-B9E9-39C93F0C6805 Q33861620-98E11198-246D-4328-8421-A4FCC44C96CD Q33874283-E878FD4A-89AB-4F5B-A475-31DCBE018787 Q34048140-F8F567CC-5C07-4FE1-A6AB-3371DB7F50AC Q34100400-EBBA511C-073E-4958-9854-D58AF5C24AC5 Q34273280-CEC470CD-9CEF-489D-B7D1-34D3235E1B4C Q34291564-3FB849A8-6A97-4C32-935A-B76BC771A825 Q34313996-C514DF7C-0CE0-476C-B849-6D1589B7F92A Q34354215-FFDA4D10-75E0-4350-B20D-3DC2B6163732 Q34420914-F313C9D2-25F9-4B6C-AFF7-2CB169403DB9 Q34428718-C0AD8809-75AA-427D-9149-A275F738DC67 Q34476551-DEB31C41-9B05-43C6-B782-8DFF2C0CCC43 Q34479003-08A25B93-AF2A-4EAD-B8A2-AC6FA197E337 Q34585874-7DF9E356-0B1D-4103-9E1C-0D25CB1A1007 Q34610562-6F768BB0-7F60-495E-B5BD-3B0DA6DEB955 Q34657786-522A2A62-0FFF-4D7A-B86C-E1F9461C50DE Q34687047-A5F33920-A66A-44C9-9627-0F0495115470 Q34708283-C3A07A20-714D-4AF9-99FB-0FE00C529395 Q34742183-2318088C-3EC5-4DBD-8470-D3D5A02F870B Q34774874-964A928E-37D9-45BC-A495-991E5C5DA4C9 Q34774884-CE1A48A4-7DDB-449A-B678-64141269EE4B Q34892464-645E334D-3477-45A3-84E0-C6724E4FDC40 Q34986181-68E57113-D514-453F-A935-DF5C1AE29E0F Q34989075-569180F8-DB04-40E2-BB30-4862B985B3F5

P2860

EGFR associated expression profiles vary with breast tumor subtype

http://www.wikidata.org/entity/Q33292502

description

2007 nî lūn-bûn

@nan

2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

EGFR associated expression profiles vary with breast tumor subtype

@ast

EGFR associated expression profiles vary with breast tumor subtype

@en

type

label

EGFR associated expression profiles vary with breast tumor subtype

@ast

EGFR associated expression profiles vary with breast tumor subtype

@en

prefLabel

EGFR associated expression profiles vary with breast tumor subtype

@ast

EGFR associated expression profiles vary with breast tumor subtype

@en

P1433

Q33292502-91B5E497-1526-4E97-A898-C14B5CA48861

P1476

Q33292502-7CCDBFAF-4CA1-464D-B538-ADE27E8849D6

P2093

Q33292502-1340BF43-BD4B-48FE-9221-C3430CAA577F

Q33292502-13CBC251-8007-49B4-A1DC-7DB4276242A4

Q33292502-54D4FBC9-A0A0-4039-B763-985856B53031

Q33292502-8A6CE00E-8825-49AB-A5C3-4590FBA1589E

Q33292502-902DD3C2-CC76-40CA-AC34-02E81E629B35

Q33292502-945008B2-27A0-4861-B97C-003B3A35D697

Q33292502-B15D7B7B-287A-4CB7-811E-C9D42A87DF63

Q33292502-B881527A-958D-446F-8ED4-1DE0DF77CEEC

Q33292502-DFEF24B2-E6DE-4ECF-8A07-B1D42BF4ABF3

Q33292502-EBD8537E-DB6F-401F-B3E2-ED2121101B51

P2860

Q33292502-017B43AE-2D57-4566-B8EB-8F8CA5947F4F

Q33292502-08BD23CF-8252-45AB-B0EE-2E8D1FA4F016

Q33292502-098A5422-6D1E-4F71-9FE3-7DA1D77DAD7D

Q33292502-0C9E5509-7C71-4AC7-8022-50C32E090043

Q33292502-0CC921C8-866A-45E3-9371-C6E989175C22

Q33292502-0D876C83-BF8E-4BF3-81B4-FB8B92B1B154

Q33292502-0D939994-481A-494D-839D-B42CC23A5AF0

Q33292502-13917FA8-4045-4985-8337-56B1DF735D4C

Q33292502-190B5C33-00F6-4BED-9C27-07E963E0ADBA

Q33292502-1E2C697A-3F30-450A-995B-E6272BAF1C0E

P2888

Q33292502-933D3754-655F-49DB-AB5D-003BDE485E5E

P304

Q33292502-FD0B87EB-8FE3-46C3-9503-E71CFB54C26A

P31

Q33292502-5C703ECB-02E9-4806-BC7E-D4FB997AAE16

P356

Q33292502-2E86126F-DCFF-48AA-9AEE-87EF6612C71B

P407

Q33292502-A28B99B3-0CB1-4AB2-9BBA-232242A6255E

P478

Q33292502-B1D560A7-DC58-4200-9D74-19FBF729FCA5

P50

Q33292502-DC4C75FD-3DD5-46F9-8DFF-F885E21AAF9B

P577

Q33292502-54EA9672-A3ED-4723-8339-EB134FDB0BBF

P5875

Q33292502-EE4D21E6-8433-418B-99AB-F389623BB87A

P6179

Q33292502-D2041E4E-1615-4D2C-9335-1C4BE8ABBF47

P698

Q33292502-CE19E4F5-F1BA-4CE8-86CA-87F6100DA883

P932

Q33292502-9971A895-B17A-48A3-A7E3-029089676A8E

P356

1471-2164-8-258

P1433

P1476

EGFR associated expression profiles vary with breast tumor subtype

@en

P2093

Carolyn I Sartor

http://www.w3.org/2001/XMLSchema#string

Cheng Fan

http://www.w3.org/2001/XMLSchema#string

Katherine A Hoadley

http://www.w3.org/2001/XMLSchema#string

Lisa A Carey

http://www.w3.org/2001/XMLSchema#string

Lynda R Sawyer

http://www.w3.org/2001/XMLSchema#string

Melissa A Troester

http://www.w3.org/2001/XMLSchema#string

Philip S Bernard

http://www.w3.org/2001/XMLSchema#string

Thais Rieger-House

http://www.w3.org/2001/XMLSchema#string

Victor J Weigman

http://www.w3.org/2001/XMLSchema#string

Xiaping He

http://www.w3.org/2001/XMLSchema#string

P2860

AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

Cytoscape: a software environment for integrated models of biomolecular interaction networks

KEGG: Kyoto Encyclopedia of Genes and Genomes

Significance analysis of microarrays applied to the ionizing radiation response

Identifying biological themes within lists of genes with EASE

Cluster analysis and display of genome-wide expression patterns

Prediction of toxicant-specific gene expression signatures after chemotherapeutic treatment of breast cell lines

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Untangling the ErbB signalling network

P2888

1471-2164-8-258

P304

258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2164-8-258

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Charles M. Perou

P577

2007-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6174952

http://www.w3.org/2001/XMLSchema#string

P6179

1019972796

http://www.w3.org/2001/XMLSchema#string

P698

17663798

http://www.w3.org/2001/XMLSchema#string

P932

2014778

http://www.w3.org/2001/XMLSchema#string